Prospective evaluation of low voltage-guided repeat ablation of atrial fibrillation.

IF 3.8 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
Dennis Lawin, Christoph Stellbrink, Sophia Schulze Lammers, Alina Hoffmann, Andrej Teren, Thorsten Lawrenz
{"title":"Prospective evaluation of low voltage-guided repeat ablation of atrial fibrillation.","authors":"Dennis Lawin, Christoph Stellbrink, Sophia Schulze Lammers, Alina Hoffmann, Andrej Teren, Thorsten Lawrenz","doi":"10.1007/s00392-025-02695-4","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Atrial fibrillation (AF) recurrences following pulmonary vein isolation (PVI) remain a substantial challenge.</p><p><strong>Aims: </strong>To evaluate repeat ablation of AF combining PVI with substrate-based left atrial ablation targeting low voltage areas (LVA).</p><p><strong>Methods: </strong>Patients with recurrent AF after prior solely PVI were enrolled. Voltage map was conducted during sinus rhythm. Repeat PVI was performed in case of PV-reconnection. Only if LVA (defined as electrogram amplitudes < 0.5 mV) were present, substrate modification was conducted by creating linear or box lesions. Arrhythmia monitoring was performed for 6 months using a photoplethysmography-based smartphone application.</p><p><strong>Results: </strong>58 patients were analysed (37.9% female, median age 66.0 years [IQR 59.8-72.3]). Reconnection of at least 1 PV was found in 49 patients (84.5%). LVA were found in 31 patients (53.4%). An anterior box lesion was created in 39.7%, anterior linear lesion in 8.6%, posterior box lesion in 17.2%, roof line in 34.5%, and posterior mitral isthmus line in 5.2% of the patients. Patients with LVA were more often female (54.8% vs. 18.5% without LVA; p = 0.0045), were at higher age (71.0 years [IQR 66.0-78.0] vs. 62.0 years [IQR 55.0-66.0] without LVA; p < 0.0001), and had higher left atrial volume indexes (50.0ml/m<sup>2</sup> [IQR 40.0-61.0] vs. 34.0ml/m<sup>2</sup> [IQR 28.0-48.0] without LVA; p = 0.0014). Arrhythmia-free survival was 66.7% in patients without LVA and 48.4% in patients with LVA (HR 0.6063; 95% CI:0.2767-1.329; p = 0.2206).</p><p><strong>Conclusion: </strong>PV reconnection and the presence of LVA constitute the main findings of repeat ablations of AF. Repeat PVI combined with a tailored ablation approach individually targeting LVA was effective and safe.</p>","PeriodicalId":10474,"journal":{"name":"Clinical Research in Cardiology","volume":" ","pages":""},"PeriodicalIF":3.8000,"publicationDate":"2025-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Research in Cardiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00392-025-02695-4","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Atrial fibrillation (AF) recurrences following pulmonary vein isolation (PVI) remain a substantial challenge.

Aims: To evaluate repeat ablation of AF combining PVI with substrate-based left atrial ablation targeting low voltage areas (LVA).

Methods: Patients with recurrent AF after prior solely PVI were enrolled. Voltage map was conducted during sinus rhythm. Repeat PVI was performed in case of PV-reconnection. Only if LVA (defined as electrogram amplitudes < 0.5 mV) were present, substrate modification was conducted by creating linear or box lesions. Arrhythmia monitoring was performed for 6 months using a photoplethysmography-based smartphone application.

Results: 58 patients were analysed (37.9% female, median age 66.0 years [IQR 59.8-72.3]). Reconnection of at least 1 PV was found in 49 patients (84.5%). LVA were found in 31 patients (53.4%). An anterior box lesion was created in 39.7%, anterior linear lesion in 8.6%, posterior box lesion in 17.2%, roof line in 34.5%, and posterior mitral isthmus line in 5.2% of the patients. Patients with LVA were more often female (54.8% vs. 18.5% without LVA; p = 0.0045), were at higher age (71.0 years [IQR 66.0-78.0] vs. 62.0 years [IQR 55.0-66.0] without LVA; p < 0.0001), and had higher left atrial volume indexes (50.0ml/m2 [IQR 40.0-61.0] vs. 34.0ml/m2 [IQR 28.0-48.0] without LVA; p = 0.0014). Arrhythmia-free survival was 66.7% in patients without LVA and 48.4% in patients with LVA (HR 0.6063; 95% CI:0.2767-1.329; p = 0.2206).

Conclusion: PV reconnection and the presence of LVA constitute the main findings of repeat ablations of AF. Repeat PVI combined with a tailored ablation approach individually targeting LVA was effective and safe.

低压引导心房颤动重复消融的前瞻性评价。
背景:肺静脉隔离(PVI)后房颤(AF)复发仍然是一个重大挑战。目的:探讨PVI联合底物基左心房低电压区(LVA)消融在房颤重复消融中的应用价值。方法:纳入既往单纯PVI后复发性房颤患者。在窦性心律时进行电压图。在pv重新连接的情况下,再次进行PVI。结果:共分析58例患者(女性37.9%,中位年龄66.0岁[IQR 59.8-72.3])。49例患者(84.5%)发现至少1个PV重新连接。LVA 31例(53.4%)。39.7%的患者出现前盒状病变,8.6%的患者出现前线状病变,17.2%的患者出现后盒状病变,34.5%的患者出现顶线,5.2%的患者出现二尖瓣峡后线。LVA患者多为女性(54.8% vs.无LVA的18.5%;p = 0.0045),无LVA的患者年龄较大(71.0岁[IQR 66.0-78.0] vs. 62.0岁[IQR 55.0-66.0];p 2 [IQR 40.0 ~ 61.0] vs.无LVA的34.0ml/m2 [IQR 28.0 ~ 48.0];p = 0.0014)。无LVA患者无心律失常生存率为66.7%,有LVA患者为48.4% (HR 0.6063;95%置信区间:0.2767—-1.329;p = 0.2206)。结论:房颤重复消融的主要表现是PV重连和LVA的存在。重复PVI联合针对LVA的个性化消融方法是有效和安全的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical Research in Cardiology
Clinical Research in Cardiology 医学-心血管系统
CiteScore
11.40
自引率
4.00%
发文量
140
审稿时长
4-8 weeks
期刊介绍: Clinical Research in Cardiology is an international journal for clinical cardiovascular research. It provides a forum for original and review articles as well as critical perspective articles. Articles are only accepted if they meet stringent scientific standards and have undergone peer review. The journal regularly receives articles from the field of clinical cardiology, angiology, as well as heart and vascular surgery. As the official journal of the German Cardiac Society, it gives a current and competent survey on the diagnosis and therapy of heart and vascular diseases.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信